Therapeutic effect of ginsenoside Rd in rats with TNBS-induced recurrent ulcerative colitis

Archives of Pharmacal Research

Volumn 35, Issue 7, 2012, Pages 1231-1239

  Yang, Xiao Lai ^a,b   Guo, Tian Kang ^a   Wang, Yan Hong ^a   Gao, Ming Tang ^b   Qin, Hong ^b   Wu, Yong Jie ^b  

^a GANSU PROVINCIAL HOSPITAL   (China)

^b LANZHOU UNIVERSITY   (China)

Author keywords

2,4,6 Trinitrobenzenesulfonic acid; Anti inflammation; Antioxidation; Ginsenoside Rd; Ulcerative colitis

Indexed keywords

GINSENOSIDE RD; GLUTATHIONE PEROXIDASE; INDUCIBLE NITRIC OXIDE SYNTHASE; MALONALDEHYDE; MYELOPEROXIDASE; NITRIC OXIDE; SUPEROXIDE DISMUTASE; TRINITROBENZENESULFONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HISTOPATHOLOGY; MALE; NEUTROPHIL; NONHUMAN; ORGAN WEIGHT; RAT; RECURRENT DISEASE; SCORING SYSTEM; ULCERATIVE COLITIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL MARKERS; COLITIS, ULCERATIVE; COLON; DISEASE MODELS, ANIMAL; GASTROINTESTINAL AGENTS; GINSENOSIDES; GLUTATHIONE PEROXIDASE; MALE; MALONDIALDEHYDE; NEUTROPHIL INFILTRATION; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; PEROXIDASE; RATS; RATS, WISTAR; RECURRENCE; SUPEROXIDE DISMUTASE; TIME FACTORS; TRINITROBENZENESULFONIC ACID;

EID: 84864947438     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-012-0714-6     Document Type: Article

References (49)

1. Baynes, J. W. and Thorpe, S. R., Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes, 48, 1-9 (1999). (Pubitemid 29019345)
2. Beck, P. L., Xavier, R., Wong, J., Ezedi, I., Mashimo, H., Mizoguchi, A., Mizoguchi, E., Bhan, A. K., and Podolsky, D. K., Paradoxical roles of different nitric oxide synthase isoforms in colonic injury. Am. J. Physiol. Gastrointest. Liver Physiol., 286, G137-G147 (2004). (Pubitemid 38055847)
3. Bradley, P. P., Priebat, D. A., Christensen, R. D., and Rothstein, G., Measurement of cutaneous inflammation estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol., 78, 206-209 (1982). (Pubitemid 12171880)
4. Cetinkaya, A., Bulbuloglu, E., Kantarceken, B., Ciralik, H., Kurutas, E. B., Buyukbese, M. A., and Gumusalan, Y., Effects of 1-carnitine on oxidant/antioxidant status in acetic acid-induced colitis. Dig. Dis. Sci., 51, 488-494 (2006).
5. Corsi, L., Effects of the novel non-peptidyl low molecular weight radical scavenger IAC in different models of inflammation: a new perspective in anti-inflammatory therapy. Curr. Med. Chem., 17, 3918-3924 (2010).
6. 2+ channels inhibits T cell cytokine production and T-box transcription factor T-bet in inflammatory bowel disease. J. Immunol., 183, 3454-3462 (2009).
7. Elson, C. O., Cong, Y., Brandwein, S., Weaver, C. T., McCabe, R. P., Mähler, M., Sundberg, J. P., and Leiter, E. H., Experimental models to study molecular mechanisms underlying intestinal inflammation. Ann. NY Acad. Sci., 859, 85-95 (1998). (Pubitemid 29021008)
8. Fantini, M. C., Monteleone, G., and Macdonald, T. T., New players in the cytokine orchestra of inflammatory bowel disease. Inflamm. Bowel Dis., 13, 1419-1423. (2007). (Pubitemid 350206856)
9. Feske, S., Calcium signalling in lymphocyte activation and disease. Nat. Rev. Immunol., 7, 690-702 (2007). (Pubitemid 47327393)
10. Gálvez, J., Coelho, G., Crespo, M. E., Cruz, T., Rodríguez-Cabezas, M. E., Concha, A., Gonzalez, M., and Zarzuelo, A., Intestinal anti-inflammatory activity of morin on chronic experimental colitis in the rat. Aliment. Pharmacol. Ther., 15, 2027-2039 (2001). (Pubitemid 34014359)
11. Giris, M., Erbil, Y., Dogru-Abbasoglu, S., Yanik, B .T., Alis, H., Olgaç, V., and Toker, G. A., The effect of heme oxygenase-1 induction by glutamine on TNBS-induced colitis. Int. J. Colorectal Dis., 22, 591-599 (2007). (Pubitemid 47097030)
12. Giris, M., Depboylu, B., Dogru-Abbasoglu, S., Erbil, Y., Olgaç, V., Alis, H., Aykaç-Toker, G., and Uysal, M., Effect of taurine on oxidative stress and apoptosis-related protein expression in trinitrobenzene sulphonic acid-induced colitis. Clin. Exp. Immunol., 152,102-110 (2008). (Pubitemid 351347551)
13. Gordon, J. N., Di Sabatino, A., and Macdonald, T. T., The pathophysiologic rationale for biological therapies in inflammatory bowel disease. Curr. Opin. Gastroenterol., 21, 431-437 (2005). (Pubitemid 40961169)
14. 2+ channels in vascular smooth muscle cells. Eur. J. Pharmacol., 548, 129-136 (2006). (Pubitemid 44397016)
15. Hagar, H. H., El-Medany, A., El-Eter, E., and Arafa, M., Ameliorative effect of pyrrolidinedithiocarbamate on acetic acid-induced colitis in rats. Eur. J. Pharmacol., 554, 69-77 (2007). (Pubitemid 44822587)
16. Han, M. and Fang, X. L., Difference in oral absorption of ginsenoside Rg1 between in vitro and in vivo models. Acta. Pharmacol. Sin., 27, 499-505 (2006).
17. Howard, A., Tahir, I., Javed, S., Waring, S. M., Ford, D., and Hirst, B. H., Glycine transporter GLYT1 is essential for glycine-mediated protection of human intestinal epithelial cells against oxidative damage. J. Physiol., 588, 995-1009 (2010).
18. Kakkar, P., Das, B., and Viswanathan, P. N., A modified spectrophotometric assay of superoxide dismutase. Indian J. Biochem. Biophys., 21, 130-132 (1984). (Pubitemid 15207169)
19. Kimura, H., Miura, S., Shigematsu, T., Ohkubo, N., Tsuzuki, Y., Kurose, I., Higuchi, H., Akiba, Y., Hokari, R., Hirokawa, M., Serizawa, H., and Ishii, H., Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's disease. Dig. Dis. Sci., 42,1047-1054 (1997). (Pubitemid 27239799)
20. Konturek, P. C., Brzozowski, T., Engel, M., Burnat, G., Gaca, P., Kwiecien, S., Pajdo, R., and Konturek, S. J., Ghrelin ameliorates colonic inflammation. Role of nitric oxide and sensory nerves. J. Physiol. Pharmacol., 60, 41-47 (2009).
21. Krawisz, J. E., Sharon, P., and Stenson, W. F., Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology, 87, 1344-1350 (1984). (Pubitemid 15201434)
22. Kurutas, E. B., Cetinkaya, A., Bulbuloglu, E., and Kantarceken, B., Effects of antioxidant therapy on leukocyte myeloperoxidase and Cu/Zn-superoxide dismutase and plasma malondialdehyde levels in experimental colitis. Mediators Inflamm., 14, 390-394 (2005). (Pubitemid 41803409)
23. Li, H., Wu, W. K., Li, Z. J., Chan, K. M., Wong, C. C., Ye, C. G., Yu, L., Sung, J. J., Cho, C. H., and Wang, M., 2,3',4,4',5'-Pentamethoxy-trans- stilbene, a resveratrol derivative, inhibits colitis-associated colorectal carcinogenesis in mice. Br. J. Pharmacol., 160, 1352-1361 (2010).
24. Li, X. L., Cai, Y. Q., Qin, H., and Wu, Y. J., Therapeutic effect and mechanism of proanthocyanidins from grape seeds in rats with TNBS-induced ulcerative colitis. Can. J. Physiol. Pharmacol., 86, 841-849 (2008).
25. Lih-Brody, L., Powell, S. R., Collier, K. P., Reddy, G. M., Cerchia, R., Kahn, E., Weissman, G. S., Katz, S., Floyd, R. A., McKinley, M. J., Fisher, S. E., and Mullin, G. E., Increased oxidative stress and decreased antioxidant defences in mucosa of inflammatory bowel disease. Dig. Dis. Sci., 41, 2078-2086 (1996). (Pubitemid 26366811)
26. Liu, H., Yang, J., Du, F., Gao, X., Ma, X., Huang, Y., Xu, F., Niu, W., Wang, F., Mao, Y., Sun, Y., Lu, T., Liu, C., Zhang, B., and Li, C., Absorption and disposition of ginsenosides after oral administration of Panax notoginseng extract to rats. Drug Metab. Dispos., 37, 2290-2298 (2009).
27. 2+ signaling in T cells. Trends Mol. Med., 13, 103-107 (2007). (Pubitemid 46341959)
28. Loguercio, C., D'Argenio, G., Delle Cave, M., Cosenza, V., Della Valle, N., Mazzacca, G., and del Vecchio Blanco, C., Direct evidence of oxidative damage in acute and chronic phases of experimental colitis in rats. Dig. Dis. Sci., 41, 1204-1211 (1996). (Pubitemid 26227894)
29. Martín, M. C., Martinez, A., Mendoza, J. L., Taxonera, C., Díaz-Rubio, M., Fernández-Arquero M., de la Concha E. G., and Urcelay, E., Influence of the inducible nitric oxide synthase gene (NOS2A) on inflammatory bowel disease susceptibility. Immunogenetics, 59, 833-837 (2007). (Pubitemid 350160028)
30. McKenzie, S. J., Baker, M. S., Buffinton, G. D., and Doe, W. F., Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease. J. Clin. Invest., 98, 136-141 (1996). (Pubitemid 26243829)
31. Murad-Regadas, S. M., Souza, M. H., Brito, G. A., Rodrigues, L. V., Regadas, F. S., and Vasconcelos, P. R., Effect of soluble fiber or fructooligosaccharide supplementation upon trinitrobenzenesulphonic acid induced colitis in rats. Acta. Cir. Bras., 21, 315-320 (2006). (Pubitemid 44544090)
32. Neurath, M., Fuss, I., and Strober, W., TNBS-colitis. Int. Rev. Immunol., 19, 51-62 (2000). (Pubitemid 30146942)
33. Ohkawa, H., Ohishi, N., and Yagi, K., Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem., 95, 351-358 (1979). (Pubitemid 9194347)
34. Orhan, H., Marol, S., Hepsen, I. f., and Sahin, G., Effects of some probable antioxidants on selenit-induced cataract formation and oxidative stress-related parameters in rats. Toxicology, 139, 219-232 (1999).
35. Palatka, K., Serfozo, Z., Veréb, Z., Hargitay, Z., Lontay, B., Erdodi, F., Bánfalvi, G., Nemes, Z., Udvardy, M., and Altorjay, I., Changes in the expression and distribution of the inducible and endothelial nitric oxide synthase in mucosal biopsy specimens of inflammatory bowel disease. Scand. J. Gastroenterol., 40, 670-680 (2005). (Pubitemid 40827529)
36. Peran, L., Sierra, S., Comalada, M., Lara-Villoslada, F., Bailón, E., Nieto, A., Concha, A., Olivares, M., Zarzuelo, A., Xaus, J., and Gálvez, J., A comparative study of the preventative effects exerted by two probiotics, Lactobacillus reuteri and Lactobacillus fermentum, in the trinitrobenzenesulfonic acid model of rat colitis. Br. J. Nutr., 97, 96-103 (2007). (Pubitemid 46662063)
37. Sun, F. F., Lai, P. S., Yue, G., Yin, K., Nagele, R. G., Tong, D. M., Krzesicki, R. F., Chin J. E., and Wong P. Y., Pattern of cytokine and adhesion molecule mRNA in hapten-induced relapsing colon inflammation in the rat. Inflammation, 25, 33-45 (2001). (Pubitemid 32225480)
38. Talero, E., Sánchez-Fidalgo, S., de la Lastra, C. A., Illanes M., Calvo, J. R., and Motilva, V., Acute and chronic responses associated with adrenomedullin administration in experimental colitis. Peptides, 29, 2001-2012 (2008).
39. Tamura, T., Cui X., Sakaguchi, N., and Akashi, M., Ginsenoside Rd prevents and rescues rat intestinal epithelial cells from irradiation-induced apoptosis. Food Chem. Toxicol., 9, 3080-3089 (2008).
40. Tüzün, A., Erdil, A., Inal, V., Aydin, A., Bagci, S., Yesilova, Z., Sayal, A., Karaeren, N., and Dagalp, K., Oxidative stress and antioxidant capacity in patients with inflammatory bowel disease. Clin. Biochem., 35, 569-572 (2002). (Pubitemid 35462134)
41. Wang, W., Wang, G. J., Xie, H. T., Sun, J. G., Zhao, S., Jiang, X. L., Li, H., Lv, H., Xu, M. J., and Wang, R., Determination of ginsenoside Rd in dog plasma by liquid chromatography-mass spectrometry after solid-phase extraction and its application in dog pharmacokinetics studies. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 852, 8-14 (2007). (Pubitemid 46839207)
42. Wang, Y. H., Yang, X. L., Wang, L., Cui, M. X., Cai, Y. Q., Li, X. L., and Wu, Y. J., Effects of proanthocyanidins from grape seed on treatment of recurrent ulcerative colitis in rats. Can. J. Physiol. Pharmacol., 88, 888-898 (2010).
43. Wu, C. F., Bi, X. L., Yang, J. Y., Zhan, J. Y., Dong, Y. X., Wang, J. H., Wang, J. M., Zhang, R, and Li, X., Differential effects of ginsenosides on NO and TNF-alpha production by LPS-activated N9 microglia. Int. Immunopharmacol., 7, 313-320 (2007). (Pubitemid 46186170)
44. Wohaieb, S. A. and Godin, D. V., Alterations in free radical tissue-defense mechanisms in streptozocin-induced diabetes in rat. Effects of insulin treatment. Diabetes, 36, 1014-1018 (1987). (Pubitemid 18088387)
45. Ye, R., Han, J., Kong, X., Zhao, L., Cao, R., Rao, Z., and Zhao, G., Protective effects of ginsenoside Rd on PC12 cells against hydrogen peroxide. Biol. Pharm. Bull., 31, 1923-1927 (2008).
46. Yokozawa, T., Satoh, A., and Cho, E. J., Ginsenoside-Rd attenuates oxidative damage related to aging in senescenceaccelerated mice. J. Pharm. Pharmacol., 6, 107-113 (2004). (Pubitemid 38195335)
47. Xie, H. T., Wang, G. J., Sun, J. G., Tucker, I., Zhao, X. C., Xie, Y. Y., Li, H., Jiang, X. L., Wang, R., Xu, M. J., and Wang, W., High performance liquid chromatographicmass spectrometric determination of ginsenoside Rg3 and its metabolites in rat plasma using solid-phase extraction for pharmacokinetic studies. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 818, 167-173 (2005). (Pubitemid 40331821)
48. Zhang, X., Zhang, D., Xu, J., Gu, J., and Zhao, Y., Determination of 25-OH-PPD in rat plasma by highperformance liquid chromatography-mass spectrometry and its application in rat pharmacokinetic studies. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 858, 65-70 (2007). (Pubitemid 47513608)
49. Zhu, F., Qian, J. M., and Pan, G. Z., The establishment of TNBS-induced experimental colitis. Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 20, 271-278 (1998).